HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Glenn F Rall Selected Research
Glenn F Rall Research Topics
Disease
11
Infections
01/2022 - 05/2002
8
Virus Diseases (Viral Diseases)
01/2019 - 09/2003
4
Central Nervous System Diseases (CNS Diseases)
01/2019 - 05/2002
1
Neoplasms (Cancer)
01/2022
1
Infectious Encephalitis
01/2021
1
Measles
01/2021
1
Encephalitis (Encephalitis, Rasmussen)
01/2021
1
Necrosis
08/2013
1
Edema (Dropsy)
12/2011
1
Multiple Sclerosis
01/2003
1
Inflammation (Inflammations)
09/2002
Drug/Important Bio-Agent (IBA)
6
Antiviral Agents (Antivirals)
IBA
11/2021 - 09/2003
3
Proteins (Proteins, Gene)
FDA Link
11/2021 - 08/2013
3
Interferons
IBA
01/2019 - 08/2013
3
RNA (Ribonucleic Acid)
IBA
01/2019 - 08/2013
3
Cytokines
IBA
08/2013 - 02/2012
2
Interferon Type I
IBA
11/2021 - 11/2015
2
Bone Marrow Stromal Antigen 2
IBA
11/2021 - 11/2015
2
Viral RNA
IBA
01/2019 - 12/2002
2
Interferon-gamma (Interferon, gamma)
IBA
10/2012 - 05/2002
1
COVID-19 Vaccines
IBA
01/2022
1
Messenger RNA (mRNA)
IBA
01/2022
1
Glutamic Acid (Glutamate)
FDA Link
01/2021
1
Pancreatic Ribonuclease (Ribonuclease A)
IBA
01/2021
1
Ribonucleoproteins
IBA
01/2021
1
Viral Proteins
IBA
01/2019
1
Receptor-Interacting Protein Serine-Threonine Kinases
IBA
08/2013
1
eIF-2 Kinase (eIF 2 Kinase)
IBA
08/2013
1
Caspase 8 (Caspase-8)
IBA
08/2013
1
Phosphotransferases (Kinase)
IBA
08/2013
1
Serine (L-Serine)
FDA Link
08/2013
1
Caspases
IBA
08/2013
1
Viral Antigens
IBA
01/2012
1
Perforin
IBA
12/2011
1
Antigens
IBA
12/2011
1
Neurokinin-1 Receptors (Neurokinin 1 Receptor)
IBA
05/2007
1
Peptides (Polypeptides)
IBA
05/2007
1
Substance P
IBA
05/2007
1
Neurotransmitter Agents (Neurotransmitter)
IBA
05/2007
1
poliovirus receptor
IBA
09/2005
1
Chemokines
IBA
09/2003
1
Vaccines
IBA
01/2003
1
Glycoproteins (Glycoprotein)
IBA
09/2002
1
Aphidicolin
IBA
06/2002
1
Mitomycin (Mitomycin-C)
FDA Link
Generic
06/2002
1
DNA (Deoxyribonucleic Acid)
IBA
06/2002
1
Nocodazole
IBA
06/2002
Therapy/Procedure
2
Therapeutics
01/2022 - 01/2021